Few Texas Latino girls initiate and complete the human papillomavirus (HPV) vaccine series, but few studies have examined predictors of initiation and completion in this group. Mothers are crucial to vaccine uptake. Using self-reported data from mothers of unvaccinated girls (n = 317), we examined the association between predictors (HPV and HPV vaccine knowledge, vaccine self-efficacy) and outcomes (initiation and completion). Despite an increase in HPV and HPV vaccine knowledge from baseline to follow-up (n = 195), we found no association between the predictors and the outcomes. Findings showed that health insurance status and study group participation (Entre Madre e Hija program or brochure only) were associated with initiation and completion.
April-June 2017 ■ Volume 40 ■ Number 2 timely vaccination for adolescents have been identified: infrequent health care visits, missed opportunities for vaccination during urgent care visits, lack of health insurance and/or a usual source of care, and lack of a physician's recommendation. [13] [14] [15] [16] Barriers to vaccination reported by mothers in the TexasMexico border area include inconvenient business hours for vaccination, lack of transportation to clinics, and out-of-pocket costs for those with private or employer-based insurance. 17 Because parents, especially mothers, are central decision-makers in their child or children's medical care, they are crucial to HPV vaccine uptake. One study on Hispanic mothers' and fathers' caregiving roles showed that mothers spent significantly more time in physical care, doctor visits, and communication with their child or children compared with fathers. 18 Because gender roles in Latino families with respect to caregiving and responsibility for children's health care decisions tend to fall within the purview of the mother, our intervention primarily focused on mothers, but our literature covers both mothers and fathers. The literature indicates that parents are more likely to report a willingness to vaccinate if they feel their child is susceptible to HPV or cervical cancer, [19] [20] [21] [22] if they believe the vaccine is effective and provides benefits, 19, 20, [22] [23] [24] [25] and if they perceive few barriers to accessing the vaccine. 22, 26 The literature also provides mixed results, 19, [21] [22] [23] 25, 27 regarding perceptions of the severity of HPV-related diseases and regarding parental attitudes toward vaccination. Approval from significant others (eg, spouse or doctor) or a parent's perception that vaccination is the norm is also associated with vaccine acceptability. 19, 21, 28, 29 Few studies have specifically assessed parent predictors of HPV vaccine initiation [30] [31] [32] [33] [34] and completion 33, 34 for their adolescent girl children. Brewer and colleagues 30 found increased HPV vaccine initiation among parents when few barriers to vaccination were perceived. The same study also found increased indications of regret when daughters who were not already vaccinated contracted HPV. Findings from Guerry and colleagues 31 showed that awareness (having heard of the vaccine), belief in the effectiveness of the vaccine, and a doctor's recommendation were positively associated with initiation. Negative attitudes among parents toward the HPV vaccine and a lack of information about the vaccine were negatively associated with initiation. Joseph and colleagues 34 found that HPV vaccine knowledge among mothers was not associated with increased vaccine initiation or completion. Tsui and colleagues 32 reported that neighborhood sociodemographic factors (eg, the percentage of census tract residents living below poverty level, the percentage of unemployed census tract residents older than 16 years, the percentage of census tract residents belonging to a minority race/ethnicity, and the percentage of census tract residents without access to a private vehicle) were not significantly associated with HPV vaccine initiation after controlling for individual-level factors (eg, the daughter's age, insurance type, usual source of care; and the mother's race/ethnicity, age and level of HPV awareness). According to Underwood and colleagues, 33 parents with more positive attitudes about the vaccine and with a female child were more likely to initiate and complete the series. The age of the female child and the type of insurance were also factors: having a high school age child and private insurance was associated with completing the series compared with having a middle school child and Medicaid. 33 The aforementioned studies focused on rural and urban African American, 30, 33, 34 Haitian, 34 mixed urban Latino and African American, 31 and mixed urban Latino and Asian American 32 populations. Few of these studies controlled for individual-level factors such as HPV and HPV vaccine knowledge, which are recognized by health promotion theories 35, 36 as contributing to the adoption and/or maintenance of HPV vaccination. Studies among underserved Hispanic populations have shown limited and sometimes inaccurate levels of HPV knowledge, especially about the virus' relationship to cervical cancer. [37] [38] [39] [40] A systematic review of the literature on barriers to HPV vaccination among US adolescents also determined that a key barrier for underserved or disadvantaged parents is a lack of knowledge regarding HPV and HPV vaccine. 41 Before vaccinating their children, parents need more information.
Bandura's social-cognitive theory 42, 43 has also shown that self-efficacy is strongly linked to health-related behaviors such as the decision to be vaccinated. Social-cognitive theory defines self-efficacy as one's confidence in being able to exert personal control 43 and is specific to a task or behavior. 42 A person evaluates the steps involved in achieving a given task or behavior and gauges his or her confidence in the ability to succeed accordingly. For example, a parent wanting to have his or her child vaccinated would first need to take the step of calling and making an appointment with the child's doctor. A self-efficacy belief related to this step would be the confidence a parent has in their ability to identify and call a location that offers HPV vaccinations and to arrange an appointment. The few studies that have examined self-efficacy in relation to HPV vaccination substantiate the premise that increasing HPV vaccine self-efficacy plays a role Copyright © 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
in increasing HPV vaccination. However, these studies 44, 45 have focused on college-age, predominantly white women. To the authors' knowledge, no studies have focused on Latino populations. There is a gap in the literature due to few studies assessing predictors, including self-efficacy, of HPV vaccine initiation and completion and focusing on underserved Latino populations living in rural, border areas in the United States. Thus, it remains unclear if current explanatory models of vaccine initiation and completion explain behavior in this population, which is disproportionately affected by cervical cancer [1] [2] [3] 46 and which is not meeting current public health HPV vaccination goals. 8, 9 In this study, we examined the association of HPV knowledge, HPV vaccine knowledge, and HPV vaccine self-efficacy on HPV vaccine initiation and completion among mothers with unvaccinated daughters aged 11 to 17 years living along the Texas-Mexico border, while controlling for covariates. We focused specifically on mothers, instead of on parents, because in our population mothers were their daughters' health care decision makers, and thus were the primary intervention target. Findings from this study will allow researchers to better understand health disparities affecting Latinos and to improve their ability to appropriately target vaccine intervention efforts 16 by considering the critical factors that parents living in border communities may encounter (eg, being non-English speakers, having low literacy skills, and experiencing disparities in accessing health information). In addition, findings will contribute to the development of interventions to reduce cases of HPV-associated cancers and diseases, which could be prevented with widespread HPV vaccination.
METHODS

Program description
The Entre Madre e Hija (EMH) program used community health workers (CHWs) and undergraduate peer educators to deliver cervical cancer prevention education and navigation to mothers and daughters in Cameron and Hidalgo counties. The EMH program utilized a single-group, pre-post design. Specific details about the program can be found elsewhere 17 ; we provide a brief overview here. Between October 2011 and April 2013, CHWs enrolled eligible participants into the program. Women who self-reported being of Hispanic ethnicity, having an unvaccinated daughter aged 11 to 17 years, and residing in Cameron or Hidalgo counties were eligible to participate. All daughters of participants were eligible to participate in the interactive education sessions facilitated by undergraduate peer educators. If women had more than 1 unvaccinated daughter aged 11 to 17 years, CHWs enrolled the daughter with the next birthday in the given calendar year, and asked the mother to provide data (eg, survey and vaccine status) only in reference to the enrolled daughter. We used the "next birthday sampling method" not only to select the daughter, but to control for biases that might arise from the mother selecting a daughter to enroll. 47 For all eligible women who agreed to participate, CHWs administered a baseline survey, provided a bilingual (English/Spanish) HPV educational brochure, and invited both mother and daughter to an education session.
Education sessions
Mothers and daughters received the 1-hour education sessions separately. Daughters received the session separately from their mothers to facilitate a secure environment in which to both ask and answer questions related to the topics discussed with the peer educator. Community health workers administered the follow-up survey to mothers after the session. Peer educators administered the presurvey before each session activity and the postsurvey to daughters after the session. A detailed description of the education content offered to mothers and daughters is published elsewhere. 17 In brief, mothers participated in didactic sessions, facilitated by a CHW using bilingual flipchart or PowerPoint and covering information on cervical cancer, HPV, the HPV vaccine, Pap test screening, and communication regarding sex. Daughters attended small group sessions covering the same educational content (except for communication about sex) as those covered in the sessions for mothers, but using interactive activities.
Referral, navigation, and follow-up calls
Mothers who attended education sessions received a community resource sheet listing clinics offering free or low-cost HPV vaccinations. In addition, 1 week after the education session, CHWs called participants for a postintervention follow-up. Community health workers asked participants if they had made an appointment or if they needed assistance making a vaccination appointment or locating a clinic (eg, navigation) for their daughter. For participants reporting scheduled appointments, CHWs made additional postintervention follow-up calls to make vaccination reminders and to confirm adherence to appointments at 2 and 6 months after the initial dose. For mothers who did not attend an education session and only received a brochure, CHWs called participants 6 months after baseline survey to For this study, we utilized the mother's baseline survey data and the 6-month postintervention assessment of the daughter's HPV vaccine status from the EMH outreach and education program. The University of Texas Health Science Center at San Antonio institutional review board deemed the study exempt (category 2).
Study setting
Hidalgo and Cameron counties have a bilingual (Spanish and English) population estimated at more than 1.3 million. 48, 49 Close to 90% of residents in these counties are Hispanic, 50 almost 40% have less than a high school education, 51, 52 and about 35% live below the poverty level. 51, 52 The US Department of Health and Human Services 53,54 also designates these counties as Medically Underserved Areas and Health Professional Shortage Areas.
Measures
Demographics
Eligible mothers provided demographic information regarding age, foreign born, the number of years living the United States, education, marital status, employment, health insurance status, health status, and language read or spoken.
HPV knowledge
To measure the mothers' HPV knowledge, we used and adapted 6 items from the Health Information National Trends Survey (HINTS) 2005, 55 including "Do you think HPV infection is rare?" and we used and modified 4-items from Kahn and colleagues, 56 such as "Do you think HPV can be cured with antibiotics?" We added 2 new items, including "Do you think HPV can be prevented by abstinence?" and "Do you think HPV can be prevented through vaccination?" Appendix 1 lists all questions for this measure. Response options were "yes" or "no." We coded correct answers as 1 (correct) and incorrect answers as 0. We created a total score by summing all the correct answers to the 11 items as outlined by Kahn and colleagues. 56 The variable had a mean = 5.23 (SD = 2.0), with observed values ranging from 0 to 10 and possible values ranging from 0 to 11.
HPV vaccine knowledge
To measure mothers' HPV vaccine knowledge, we used 3 items adapted from Kahn and colleagues, 45 including "The HPV vaccine can prevent pregnancy" and "Women who get the HPV vaccine should continue to get Pap test." Response options were "true" or "false." Appendix 1 lists all questions for this measure. Following the directions outlined by Kahn and colleagues, 45 we created a total sum score by using the mean 2.20 (SD = 0.85) from the 3 items, which had both observed and possible values ranging from 0 to 3.
HPV vaccine self-efficacy
To measure HPV vaccine self-efficacy, we adapted items from a validated Pap-test self-efficacy scale.
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The 7 items adapted included "How sure are you that you can schedule an appointment to get the HPV vaccine for your daughter?" and "How sure are you that you can ask your daughter's doctor for the HPV vaccine?" Appendix 1 lists all questions for this measure. Response options ranged from "not sure at all" to "completely sure." The internal consistency of the data was 0.92 with current data. We calculated a sum scale score based on the mean 31.02 (SD = 4.60) from 7 items. The scale had both observed and possible values ranging from 7 to 35.
HPV vaccine initiation and completion
The number of HPV vaccine doses ranged from 0 to 3 doses. From mothers' self-report at the 6-month postintervention follow-up, we computed 2 vaccine status variables: HPV vaccine initiation = 1 (yes) if doses > 0 and HPV vaccine completion = 1 (yes) if doses = 3.
Study group
We assigned participants to 1 of 2 groups: mothers who attended a 1-hour education session (EMH program) and mothers who never attended an education session and received only a brochure (brochure only).
Statistical analysis
We used STATA 11.0 for all analyses. 58 Of the 607 mothers enrolled in the EMH program, we utilized data from those mothers who completed a baseline survey and had an unvaccinated daughter at baseline (n = 371). Mothers missing data (n = 15) on covariates were removed, leaving a final sample of 357 Hispanic mothers for bivariate and multivariable analyses. To describe a change in HPV and HPV vaccine knowledge from baseline to followup, we used data for mothers who completed the program and had complete data at both time periods (n = 195). To describe the sample and the variable distribution, we utilized descriptive statistics. We individually tested for differences among the independent variables, outcome variables, and covariates, using 1-way analyses of variance (ANOVAs) and chi-square analyses. To assess the association between independent variables (HPV knowledge, HPV vaccine knowledge, and self-efficacy) and HPV vaccine initiation and completion, we calculated bivariate prevalence odds ratios (ORs) and 95% confidence intervals.
We identified confounders utilizing a 10% change between unadjusted and adjusted ORs 59 and the log likelihood test (P ≤ .05). 60 In the event of discovering a 10% change where the results of the log likelihood test (P ≤ .05) were not statistically significant, or vice versa, we classified the covariates as confounders. If we were uncertain whether a variable was a confounder, then we consulted the literature to reach a final decision.
The multivariable logistic regression model included the independent variables (HPV knowledge, HPV vaccine knowledge, and self-efficacy) and confounders identified. We entered all variables at one time into the model and then removed them, using the log likelihood test. 60 The final model included both confounders contributing significantly to the model and pertinent variables from the literature. We also conducted the goodness-of-fit test on the final model. Table 1 presents demographic data for the sample. Participants were primarily foreign-born from Mexico or Central America (86%), read or spoke mostly Spanish (84%), were married (71%), and had a mean age of 38 (SD = 7.8) years. Foreignborn mothers had a mean of 14 (SD = 7.0) years living in the United States. The majority of mothers were unemployed (85%), had less than a high school education (81%), and a household income less than $10 000 (73%). Mothers' mean HPV knowledge score was 5.2 (SD = 2.0; range 0-10); and mean HPV vaccine knowledge score was 2.2 (SD = 0.8; range 0-3). Almost all mothers (90%) were uninsured and over two-fifths (43%) reported their health status as good. Among EMH participants, 61% of daughters initiated the HPV vaccine series and 34% completed it.
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RESULTS
Demographics
Bivariate analysis
No significant differences were found between independent variables and covariates or outcomes at the bivariate level. Using a significance level of . Table 2 shows the bivariate analyses between the independent variables, vaccine initiation, and vaccine completion. There was no significant associ- 
Multivariable analysis
The covariates included in the final model for both vaccine initiation and completion were education, employment, foreign-born, health insurance status, health status, and study group (Table 3) . The covariate that varied between both final models was mother's age. After adjusting for these covariates 
DISCUSSION
Despite finding significant increases in mothers' HPV and vaccine knowledge from baseline to follow-up, we found no associations between the predictors (HPV and HPV vaccine knowledge, vaccine self-efficacy) and the outcomes (vaccine initiation and completion). Mothers who participated in the EMH program, compared with the brochureonly group, were also more likely to initiate and complete the vaccine series. Our findings were similar to those of Joseph and colleagues, 34 who found in their clinic-based intervention that increases in mothers' HPV vaccine knowledge did not influence adolescent vaccination coverage in their study. Because mothers are the primary decision makers in vaccinating children younger than 18 years, limited HPV and vaccine knowledge among Hispanic mothers is a legitimate concern. 38, 61 However, despite health promotion theories recognizing knowledge as crucial to the adoption and/or maintenance of HPV vaccination, 35, 62 our findings suggest that increases in knowledge alone were not sufficient for Hispanic mothers to obtain the HPV vaccine for their daughters. Future studies should not only increase HPV and vaccine knowledge but also explore evidence-based health care systembased strategies such as providing clinic-based patient education for adolescents and their parents, strengthening provider recommendations, and offering provider and client reminders/recalls to increase vaccination rates. 63 Our findings also suggest that mothers with health insurance were less likely to have their daughter initiate and complete the vaccine series. Our sample of Hispanic mothers was predominantly Spanish-speaking (84%), had less than a high school education (81%), and had household income less than $10 000 (73%). Given these circumstances, our mothers may live in areas targeted for placement of safety net vaccination services for low-income children; thus, their children may actually have more access to the vaccine. In addition, Texas has the Vaccines for Children (VFC) Program, which subsidizes vaccines for low-income children. 64 The VFC Program also covers new vaccines after recommendations are passed by the ACIP, allowing these vaccines to be available to lowincome girls even before the vaccines are covered under commercial insurance programs. 64 Furthermore, low-income girls with private insurance may also have to cover additional out-of-pocket vaccine costs and/or may encounter other barriers to care. 65 At the time of this study, the Affordable Care Act did not exist to reduce out-of-pocket costs for this vaccine, and although the VFC Program covers the vaccine itself, patients would still need to pay an administration fee for each vaccine received. 63 In addition, unlike Federally Qualified Health Centers in rural areas, private doctors may not have the HPV vaccine readily available. Our findings, coupled with those of others, demonstrate a need to provide enhanced access to vaccine services for those girls who may be uninsured or underinsured. This study's limitations include its cross-sectional study design, potential introduction of information bias, focus of the data only on unvaccinated girls aged 11 to 17 years, and a lack of consistent comparability with state and national data. The study provides a glimpse of Hispanic girls' vaccine initiation and completion using mothers' data at onetime point. As such, we cannot determine if the independent variables caused or preceded the outcome. Despite studies 66 indicating that mothers' self-reporting of daughters' vaccination status may be more accurate compared with reports from other caregivers, information bias may have resulted from measuring our outcome in this manner, rather than using an objective source such as the daughters' vaccination records. This approach may have resulted in mothers overreporting their daughters' receipt of the vaccine. Future studies should attempt to explore differences between self-reporting and using objective data from patient medical records and/or state immunization registries. Next, the authors conceptualized and received funding for the study prior to ACIP's recommendation of the HPV vaccine for boys and men. Thus, the findings are limited to girls, which limits their generalizability to current ACIP recommendations and practices. In addition, we do not know if the same predictors influence the mothers' vaccine initiation and completion for sons. We recommend further research into similarities and differences in predictors by a
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April-June 2017 ■ Volume 40 ■ Number 2 child's gender. Finally, because of a reporting differences (national and state organizations, including NIS-Teen and the Texas Cancer Plan, specifying different age ranges for HPV vaccination rate data), it is difficult to compare study data across the state and nation.
Given the null findings reported in our study, we suggest that future studies utilize an objective outcome measure for vaccination status instead of selfreport, which may be subject to recall bias. In addition, HPV knowledge and HPV vaccine knowledge items were selected from published literature and national surveillance tools (eg, HINTS, BRFSS) developed primarily for English-speaking populations and translated to Spanish for this study. The development and testing of measures for low-literate Hispanic populations are also critical, considering that parents like those in our study sample were mostly Spanish speakers, had low literacy skills, and experienced disparities in accessing health information and the vaccine. 67 Future research should explore reasons why some mothers in our sample did not respond favorably to the vaccine uptake program. Knowing these reasons, researchers would be better equipped to provide services and programs for these women to get their daughters vaccinated. These findings assist in identifying appropriate intervention strategies to enhance vaccine initiation and completion in border communities. By increasing HPV vaccine initiation and completion among Hispanic girls, future interventions have the potential not only to reduce cervical cancer incidence and mortality among Latinas along the Texas-Mexico border (Hidalgo and Cameron counties), but also to reduce health disparities associated with HPV and other HPV-related cancers.
